natgillin/translations-raw huggingface dataset:
Aktivstoffet emamectin, som opført i bilag I, godkendes på de betingelser, der er fastsat i samme bilag.
The active substance emamectin, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Om nødvendigt ændrer eller tilbagekalder medlemsstaterne i henhold til forordning (EF) nr. 1107/2009 senest den 31. oktober 2014 eksisterende godkendelser af plantebeskyttelsesmidler, der indeholder emamectin som aktivstof.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing emamectin as an active substance by 31 October 2014.
Uanset stk. 1 revurderer medlemsstaterne for hvert godkendt plantebeskyttelsesmiddel, der indeholder emamectin, enten som eneste aktivstof eller som ét af flere aktivstoffer, som alle er optaget i bilaget til gennemførelsesforordning (EU) nr. 540/2011 senest pr. 30. april 2014, midlet i overensstemmelse med de ensartede principper i artikel 29, stk. 6, i forordning (EF) nr. 1107/2009 på grundlag af et dossier, der opfylder kravene i bilag III til direktiv 91/414/EØF, idet der samtidig tages højde for kolonnen vedrørende særlige bestemmelser i bilag I til nærværende forordning.
By way of derogation from paragraph 1, for each authorised plant protection product containing emamectin as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 30 April 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
hvis det drejer sig om et middel, der indeholder emamectin som eneste aktivstof, om nødvendigt ændre eller tilbagekalde godkendelsen senest den 31. oktober 2015, eller
in the case of a product containing emamectin as the only active substance, where necessary, amend or withdraw the authorisation by 31 October 2015 at the latest; or
hvis det drejer sig om et middel, der indeholder emamectin som ét af flere aktivstoffer, om nødvendigt ændre eller tilbagekalde godkendelsen senest den 31. oktober 2015 eller senest den dato, der er fastsat for en sådan ændring eller tilbagekaldelse i den eller de pågældende retsakter, hvorved det eller de pågældende stoffer blev optaget i bilag I til direktiv 91/414/EØF, eller hvorved det eller de pågældende stoffer blev godkendt, alt efter hvilket der er det seneste tidspunkt.
in the case of a product containing emamectin as one of several active substances, where necessary, amend or withdraw the authorisation by 31 October 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
Den anvendes fra den 1. maj 2014.
It shall apply from 1 May 2014.
(tidligere 137335-79-6) og 123997-28-4
(formerly 137335-79-6) and 123997-28-4
emamectinbenzoat: 155569-91-8
emamectin benzoate: 155569-91-8
(tidligere 137512-74-4 og 179607-18-2)
(formerly 137512-74-4 and 179607-18-2)
emamectin B1a benzoat: 138511-97-4
emamectin B1a benzoate: 138511-97-4
emamectin B1b benzoat: 138511-98-5
emamectin B1b benzoate: 138511-98-5
CIPAC-nr.:
CIPAC No
emamectinbenzoat: 791.412
emamectin benzoate: 791.412
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranosid
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranosid
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
Emamectin B1a benzoat:
Emamectin B1a benzoate:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranosidbenzoat
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside benzoate
Emamectin B1b benzoat:
Emamectin B1b benzoate:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranosidbenzoat
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside benzoate
som emamectinbenzoat på vandfri basis
as emamectin benzoate anhydrous
(en blanding af minimum 920 g/kg emamectin B1a benzoat og maksimum 50 g/kg emamectin B1b benzoat)
(a mixture of min. 920 g/kg emamectin B1a benzoate and max. 50 g/kg emamectin B1b benzoate)
Med henblik på gennemførelsen af de i artikel 29, stk. 6, i forordning (EF) nr. 1107/2009 nævnte ensartede principper skal der tages hensyn til konklusionerne i den reviderede vurderingsrapport om emamectin, særlig tillæg I og II, som færdigbehandlet i Den Stående Komité for Fødevarekæden og Dyresundhed den 16. juli 2013.
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on emamectin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
risikoen for hvirvelløse dyr, der ikke er målarter
the risk to non-target invertebrates;
Ansøgeren fremlægger bekræftende oplysninger om risikoen for enantioselektiv metabolisering eller nedbrydning.
The applicant shall submit confirmatory information as regards the risk of enantio-selective metabolisation or degradation.
Ansøgeren forelægger Kommissionen, medlemsstaterne og autoriteten de relevante oplysninger to år efter vedtagelsen af det relevante vejledende dokument om vurderingen af isomerblandinger.
The applicant shall submit to the Commission, Member States and the Authority the relevant information two years after adoption of the pertinent guidance document on evaluation of isomer mixtures.
Ansøgeren forelægger Kommissionen, medlemsstaterne og autoriteten de relevante oplysninger to år efter vedtagelsen af det relevante vejledende dokument om vurderingen af isomerblandinger.«
The applicant shall submit to the Commission, Member States and the Authority the relevant information two years after adoption of the pertinent guidance document on evaluation of isomer mixtures.’
Med hensyn til emamectin er betingelserne i artikel 80, stk. 1, litra a), i forordning (EF) nr. 1107/2009 opfyldt ved Kommissionens beslutning 2007/669/EF [3].
For emamectin the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2007/669/EC [3].
Kommissionens gennemførelsesforordning (EU) nr. 829/2013
Commission Implementing Regulation (EU) No 829/2013
om godkendelse af aktivstoffet Pseudomonas sp. stamme DSMZ 13134, jf. Europa-Parlamentets og Rådets forordning (EF) nr. 1107/2009 om markedsføring af plantebeskyttelsesmidler, og om ændring af bilaget til gennemførelsesforordning (EU) nr. 540/2011
approving the active substance Pseudomonas sp. strain DSMZ 13134, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
Nederlandene modtog den 28. august 2007 en ansøgning i henhold til artikel 6, stk. 2, i direktiv 91/414/EØF fra Sourcon-Padena GmbH & Co. KG om optagelse af aktivstoffet Pseudomonas sp. stamme DSMZ 13134 i bilag I til direktiv 91/414/EØF.
In accordance with Article 6(2) of Directive 91/414/EEC the Netherlands received on 28 August 2007 an application from Sourcon-Padena GmbH & Co. KG for the inclusion of the active substance Pseudomonas sp. strain DSMZ 13134 in Annex I to Directive 91/414/EEC.
Ved beslutning 2008/599/EF blev det bekræftet, at dossieret var fuldstændigt og således principielt kunne anses for at opfylde data- og informationskravene i bilag II og III til direktiv 91/414/EØF.
Decision 2008/599/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Den udpegede rapporterende medlemsstat forelagde et udkast til vurderingsrapport den 3. november 2009.
The designated rapporteur Member State submitted a draft assessment report on 3 November 2009.
Autoriteten forelagde den 12. november 2012 Kommissionen sin konklusion om vurderingen af pesticidrisikoen ved aktivstoffet Pseudomonas sp. stamme DSMZ 13134 [4].
The Authority presented to the Commission its conclusion [4] on the pesticide risk assessment of the active substance Pseudomonas sp. strain DSMZ 13134 on 12 November 2012.
Udkastet til vurderingsrapport og autoritetens konklusioner blev behandlet af medlemsstaterne og Kommissionen i Den Stående Komité for Fødevarekæden og Dyresundhed, og behandlingen blev afsluttet den 16. juli 2013 med Kommissionens reviderede vurderingsrapport om Pseudomonas sp. stamme DSMZ 13134.
The draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 16 July 2013 in the format of the Commission review report for Pseudomonas sp. strain DSMZ 13134.
Det fremgår af de forskellige undersøgelser, at plantebeskyttelsesmidler, der indeholder Pseudomonas sp. stamme DSMZ 13134, kan forventes generelt at opfylde kravene i artikel 5, stk. 1, litra a) og b), og artikel 5, stk. 3, i direktiv 91/414/EØF, især med hensyn til de anvendelsesformål, der er undersøgt og udførligt beskrevet i Kommissionens reviderede vurderingsrapport.
It has appeared from the various examinations made that plant protection products containing Pseudomonas sp. strain DSMZ 13134 may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Pseudomonas sp. stamme DSMZ 13134 bør derfor godkendes.
It is therefore appropriate to approve Pseudomonas sp. strain DSMZ 13134.
Medlemsstaterne bør have en frist på seks måneder efter godkendelsen til at tage eksisterende godkendelser af plantebeskyttelsesmidler, der indeholder Pseudomonas sp. stamme DSMZ 13134, op til fornyet overvejelse.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing Pseudomonas sp. strain DSMZ 13134.
Aktivstoffet Pseudomonas sp. stamme DSMZ 13134, som opført i bilag I, godkendes på de betingelser, der er fastsat i samme bilag.
The active substance Pseudomonas sp. strain DSMZ 13134, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Om nødvendigt ændrer eller tilbagekalder medlemsstaterne i henhold til forordning (EF) nr. 1107/2009 senest den 31. juli 2014 eksisterende godkendelser af plantebeskyttelsesmidler, der indeholder Pseudomonas sp. stamme DSMZ 13134 som aktivstof.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing Pseudomonas sp. strain DSMZ 13134 as an active substance by 31 July 2014.
Uanset stk. 1 revurderer medlemsstaterne for hvert godkendt plantebeskyttelsesmiddel, der indeholder Pseudomonas sp. stamme DSMZ 13134, enten som eneste aktivstof eller som ét af flere aktivstoffer, der alle er optaget i bilaget til gennemførelsesforordning (EU) nr. 540/2011 senest pr. 31. januar 2014, midlet i overensstemmelse med de ensartede principper i artikel 29, stk. 6, i forordning (EF) nr. 1107/2009 på grundlag af et dossier, der opfylder kravene i bilag III til direktiv 91/414/EØF, idet der samtidig tages højde for kolonnen vedrørende særlige bestemmelser i bilag I til nærværende forordning.
By way of derogation from paragraph 1, for each authorised plant protection product containing Pseudomonas sp. strain DSMZ 13134 as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 31 January 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
hvis det drejer sig om et produkt, der indeholder Pseudomonas sp. stamme DSMZ 13134 som eneste aktivstof, om nødvendigt ændre eller tilbagekalde godkendelsen senest den 31. juli 2015, eller
in the case of a product containing Pseudomonas sp. strain DSMZ 13134 as the only active substance, where necessary, amend or withdraw the authorisation by 31 July 2015 at the latest; or
hvis det drejer sig om et middel, der indeholder Pseudomonas sp. stamme DSMZ 13134 som ét af flere aktivstoffer, om nødvendigt ændre eller tilbagekalde godkendelsen senest den 31. juli 2015 eller senest den dato, der er fastsat for en sådan ændring eller tilbagekaldelse i den eller de pågældende retsakter, hvorved det eller de pågældende stoffer blev optaget i bilag I til direktiv 91/414/EØF, eller hvorved det eller de pågældende stoffer blev godkendt, alt efter hvilket der er det seneste tidspunkt.
in the case of a product containing Pseudomonas sp. strain DSMZ 13134 as one of several active substances, where necessary, amend or withdraw the authorisation by 31 July 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
Foreligger online: www.efsa.europe.eu
Available online: www.efsa.europa.eu
Pseudomonas sp. stamme DSMZ 13134
Pseudomonas sp. strain DSMZ 13134
Samlingens nr.: DSMZ 13134
Collection number: DSMZ 13134
Minimumskoncentration: 3 × 1014 CFU/kg
Minimum concentration: 3 × 1014 cfu/kg
Med henblik på gennemførelsen af de i artikel 29, stk. 6, i forordning (EF) nr. 1107/2009 nævnte ensartede principper skal der tages hensyn til konklusionerne i den reviderede vurderingsrapport om Pseudomonas sp. stamme DSMZ 13134, særlig tillæg I og II, som færdigbehandlet i Den Stående Komité for Fødevarekæden og Dyresundhed den 16. juli 2013.
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Pseudomonas sp. strain DSMZ 13134, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
Ved denne samlede vurdering skal medlemsstaterne være særligt opmærksomme på beskyttelsen af brugerne og arbejdstagerne i betragtning af, at Pseudomonas sp. stamme DSMZ 13134 skal betragtes som et potentielt sensibiliserende stof.
In this overall assessment Member States shall pay particular attention to the protection of operators and workers, taking into account that Pseudomonas sp. strain DSMZ 13134 is to be considered as a potential sensitizer.
Ansøgeren fremlægger oplysninger, der bekræfter fraværet af en potentiel akut intratracheal og intraperitoneal toksicitet/infektivitet/patogenicitet.
The applicant shall submit information to confirm the absence of an acute intratracheal and intraperitoneal toxicity/infectivity/pathogenicity potential.
Ansøgeren fremlægger disse oplysninger for Kommissionen, medlemsstaterne og autoriteten senest den 31. januar 2016.
The applicant shall submit to the Commission, the Member States and the Authority that information by 31 January 2016.
Minimumskoncentra-tion: 3 × 1014 CFU/kg
Minimum concentration: 3×1014 cfu/kg
Ansøgeren fremlægger disse oplysninger for Kommissionen, medlemsstaterne og autoriteten senest den 31. januar 2016.«
The applicant shall submit to the Commission, the Member States and the Authority that information by 31 January 2016.’
Med hensyn til Pseudomonas sp. stamme DSMZ 13134 er betingelserne i artikel 80, stk. 1, litra a), i forordning (EF) nr. 1107/2009 opfyldt ved Kommissionens beslutning 2008/599/EF [3].
For Pseudomonas sp. strain DSMZ 13134 the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2008/599/EC [3].
Kommissionens gennemførelsesforordning (EU) nr. 830/2013
Commission Implementing Regulation (EU) No 830/2013
Kommissionens gennemførelsesforordning (EU) nr. 831/2013
Commission Implementing Regulation (EU) No 831/2013
om 199. ændring af Rådets forordning (EF) nr. 881/2002 om indførelse af visse specifikke restriktive foranstaltninger mod visse personer og enheder, der har tilknytning til Al-Qaida-organisationen
amending for the 199th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the Al Qaida network
Den 19. august 2013 besluttede sanktionskomitéen under FN's Sikkerhedsråd at fjerne en fysisk person fra listen over de personer, grupper og enheder, der er omfattet af indefrysningen af pengemidler og økonomiske ressourcer, efter at have behandlet den pågældende persons anmodning om at blive fjernet fra listen og den fyldestgørende rapport fra det ombudsmandskontor, der blev oprettet i medfør af FN's Sikkerhedsråds resolution 1904(2009).
On 19 August 2013 the Sanctions Committee of the United Nations Security Council (UNSC) decided to remove one natural person from its list of persons, groups and entities to whom the freezing of funds and economic resources should apply after considering a de-listing request submitted by this person and the Comprehensive Report of the Ombudsperson established pursuant to United Nations Security Council Resolution 1904(2009).
Den 5. august 2013 besluttede sanktionskomitéen under FN's Sikkerhedsråd endvidere at tilføje tre enheder til listen.
Furthermore, on 5 August 2013, the Sanctions Committee of the UNSC decided to amend three entries on the list.
Følgende punkt under overskriften "Fysiske personer" udgår: "Mohammed Daki. Adresse: Casablanca, Marokko.
The following entry under the heading ‘Natural persons’ is deleted:
Fødselsdato: 1.12.1973. Fødested: Sulaimaniya, Irak. Nationalitet: irakisk. Pasnr.: Tysk rejsebevis ("Reiseausweis") A 0020375. Andre oplysninger: (a) fængslet i Tyskland. (b) medlem af Ansar Al-Islam. Den i artikel 2a, stk. 4, litra b), omhandlede dato: 6.12.2005" under overskriften "Fysiske personer" affattes således: "Ata Abdoulaziz Rashid (alias (a) Ata Abdoul Aziz Barzingy, (b) Abdoulaziz Ata Rashid).
The entry ‘Ata Abdoulaziz Rashid (alias (a) Ata Abdoul Aziz Barzingy, (b) Abdoulaziz Ata Rashid). Date of birth: 1.12.1973. Place of birth: Sulaimaniya, Iraq. Nationality: Iraqi. Passport No: German travel document (‘Reiseausweis’) A 0020375. Other information: (a) In prison in Germany; (b) Member of Ansar Al-Islam. Date of designation referred to in Article 2a (4) (b): 6.12.2005.’ under the heading ‘Natural persons’ shall be replaced by the following:
Fødselsdato: 1.12.1973. Fødested: Sulaimaniya, Irak. Nationalitet: irakisk. Adresse: Tyskland. Den i artikel 2a, stk. 4, litra b), omhandlede dato: 6.12.2005."
‘Ata Abdoulaziz Rashid (alias (a) Ata Abdoul Aziz Barzingy, (b) Abdoulaziz Ata Rashid). Date of birth: 1.12.1973. Place of birth: Sulaimaniya, Iraq. Nationality: Iraqi. Address: Germany. Date of designation referred to in Article 2a (4) (b): 6.12.2005.’
Punktet "Ibrahim Mohamed Khalil (alias (a) Khalil Ibrahim Jassem, (b) Khalil Ibrahim Mohammad, (c) Khalil Ibrahim Al Zafiri, (d) Khalil). Fødselsdato: (a) 2.7.1975, (b) 2.5.1972, (c) 3.7.1975, (d) 1972, (e) 2.5.1975. Fødested: (a) Mosul, Irak (b) Baghdad, Irak. Nationalitet: irakisk. Pasnr.: Tysk rejsebevis ("Reiseausweis") A 0003900. Adresse: Tyskland. Andre oplysninger: fængslet i Tyskland. Den i artikel 2a, stk. 4, litra b), omhandlede dato: 6.12.2005" under overskriften "Fysiske personer" affattes således: "Ibrahim Mohamed Khalil (alias (a) Khalil Ibrahim Jassem, (b) Khalil Ibrahim Mohammad, (c) Khalil Ibrahim Al Zafiri, (d) Khalil).
The entry ‘Ibrahim Mohamed Khalil (alias (a) Khalil Ibrahim Jassem, (b) Khalil Ibrahim Mohammad, (c) Khalil Ibrahim Al Zafiri, (d) Khalil). Date of birth: (a) 2.7.1975, (b) 2.5.1972, (c) 3.7.1975, (d) 1972, (e) 2.5.1975. Place of birth: (a) Mosul, Iraq (b) Baghdad, Iraq. Nationality: Iraqi. Passport No: German travel document (‘Reiseausweis’) A 0003900. Address: Germany. Other information: In prison in Germany. Date of designation referred to in Article 2a (4) (b): 6.12.2005.’ under the heading ‘Natural persons’ shall be replaced by the following:
Nationalt identitetsnr.: 02092811 (tysk nationalt identitetskort ("Bundespersonalausweis"), udstedt i Ulm, Tyskland, udløbet den 6.4.2010). Andre oplysninger: (a) Medlem af Islamic Jihad Union (IJU), også kendt som Islamic Jihad Group.
National identification No: 702092811 (German national identity card (Bundespersonalausweis), issued in Ulm, Germany, expired on 6.4.2010).
tilbageholdt i Tyskland siden juni 2010.
Other information: (a) Member of the Islamic Jihad Union (IJU), also known as the Islamic Jihad Group; (b) In detention in Germany as of June 2010.
Den i artikel 2a, stk. 4, litra b), omhandlede dato: 18.6.2009." under overskriften "fysiske personer" affattes således: "Atilla Selek (alias Muaz).
Date of designation referred to in Article 2a (4) (b): 18.6.2009.’ under the heading ‘Natural persons’ shall be replaced by the following:
Fødselsdato: 28.2.1985. Fødested: Ulm, Tyskland. Nationalt identifikationskort nr.: L1562682 (identitetspapir udstedt af udlændingemyndighederne i Freiburg, Tyskland).
‘Atilla Selek (alias Muaz). Date of birth: 28.2.1985. Place of birth: Ulm, Germany. National identification No: L1562682 (Identity paper issued by the Foreigners’ Authority in Freiburg, Germany).
Adresse: Kurwaldweg 1, 75365 Calw, Tyskland
Address: Kurwaldweg 1, 75365 Calw, Germany